Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gigaohm
South San Francisco & San Carlos, California, United Statesstream.gigaohm.bio ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
GigaGen has pioneered single-cell technologies to create recombinant polyclonal and monoclonal antibodies that mimic or improve upon natural human immune responses. Their lead programs include a recombinant hyperimmune for COVID‑19 (GIGA‑2050), a monoclonal anti–CTLA‑4 with improved safety profile over ipilimumab, and a hepatitis B candidate now in Phase 1 trials. The company’s approach enables faster development of potent therapies with potentially fewer side effects than traditional methods.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyPolyclonal antibodyRecombinant polyclonal antibodyT cell therapy (preclinical/early research)
- Industry
- Biotech
02
Partnerships
Grifols (strategic partnership/acquisition)Waisman Biomanufacturing (GMP manufacturing support)Goodwin Biotechnology (GMP manufacturing support)
Beyond the preview
Go deeper on Gigaohm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gigaohm.